Collategene TM

Related by string. * : Collategene / TMD . Tm . TMs . TMS . tm : FinancialWire tm website . Contact FinancialWire tm . TM EA SPORTS . Forrester Wave TM . Ibis T# TM Biosensor . Xerox Phaser TM . Addressing Psoriasis TM . Nintendo GameCube TM . Citrix Synergy TM . through eReleases TM . Impart IQ TM . AMD Opteron TM . ICO mim TM . Onko Sure TM . Solaris TM . Augment TM . FinancialWire tm . deCODE Glaucoma TM * *

Related by context. Frequent words. (Click for all words.) 54 Nimotuzumab 53 MOZOBIL 51 Orphan Drug designation 51 Orphan Drug 50 AP# [003] 50 Fast Track Designation 50 teduglutide 49 Phenoptin 49 recombinant human 49 ThermoDox ® 49 Loramyc ® 48 Clinical Trial 48 drug conjugate 48 VEGF Trap 47 oncology indications 47 Marketing Authorization Application 47 Orphan Drug Designation 47 Protectan CBLB# 47 autologous cell 47 ONCONASE 46 methylnaltrexone 46 hypoparathyroidism 46 opioid induced constipation 46 injectable formulation 46 New Drug IND 46 DAVANAT R 46 ATryn R 46 alogliptin 46 Acute Myeloid Leukemia AML 46 taliglucerase alfa 46 Marqibo 45 Topical Interferon Alpha 2b 45 MGCD# [001] 45 CF# [002] 45 tamibarotene 45 Restanza 45 MOR# 45 sodium Injection 45 humanized monoclonal antibody 45 cutaneous T cell 44 Alpharadin 44 Phase IIa trial 44 Biologics License Application BLA 44 preclinical 44 Biologics License Application 44 voclosporin 44 Marketing Authorization Application MAA 44 CBLB# 44 Homspera 44 Phase 2b trial 44 Investigational Device Exemption IDE 44 relapsed multiple myeloma 44 clofarabine 43 PXD# 43 confirmatory Phase III 43 sBLA 43 INDs 43 diabetic macular edema DME 43 TELCYTA 43 investigational 43 Phase Ib 42 carfilzomib 42 Rhucin 42 investigational compound 42 orphan drug 42 hematological malignancies 42 Phase III clinical trials 42 Investigational 42 Phase III 42 Cimzia ® 42 IND enabling 42 investigational drug 42 Apricus Bio 41 phase IIa 41 Phase III clinical 41 VQD 41 Fast Track designation 41 phase 2a 41 human monoclonal antibody 41 vilazodone 41 crofelemer 41 tezampanel 40 Fodosine TM 40 Rhucin ® 40 New Drug Application 40 Phase 2a clinical 40 clinical trial 40 NGX# 40 intravenous formulation 40 ecallantide 40 Phase 2b clinical 40 Phase 2b 39 dose escalation trial 39 Pharmion Corporation 39 Phase 1b clinical 39 Phase IIb clinical 39 Phase IIa clinical 39 AEOL # 39 sNDA 39 arimoclomol 39 Phase II

Back to home page